Placeholder Banner

Senior Leadership Team at BIO

Meet the leaders behind the Biotechnology Innovation Organization. 

Rachel King, Interim CEO of BIO
Rachel King, Interim CEO

Rachel King assumed the leadership of the Biotechnology Innovation Organization (BIO) as interim CEO on November 1, 2022. Mrs. King is  co-founder and former CEO of GlycoMimetics, Inc. (GMI). Before founding GMI, she was an Executive in Residence at New Enterprise Associates (NEA), one of the nation’s leading venture capital firms. Mrs. King came to NEA after serving as a senior vice president of Novartis Corporation. Before joining Novartis, Mrs. King spent 10 years with Genetic Therapy, Inc. through the company’s early stage, initial public offering and eventual sale to Novartis.

She also served as Chair of the Maryland Life Sciences Advisory Board under former Governor Martin O’Malley. Mrs. King now serves on the boards of Novavax, Inc. and the University of Maryland BioPark. She received her B.A. degree from Dartmouth College and her M.B.A. from Harvard Business School.

Esham Cartier
Dr. Cartier Esham
Chief Science Officer
BIO
Tonia Fykes
Tonia Fykes
Chief Events and Industry Programs Officer
BIO
Stephen Jasko
Stephen Jasko
Chief Financial Officer and Executive Vice President of Business Development
BIO
Rich Masters BIO
Rich Masters
Chief Public Affairs & Marketing Officer
BIO
bio-staff-pm
Peter McHugh
Chief Legal Officer
BIO
John Murphy
John Murphy
Chief Policy Officer
BIO
Nick Shipley
Nick Shipley
Chief Advocacy Officer
BIO
Kathryn Tecosky
Kathryn Tecosky
Chief People Officer
BIO